查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1429266

石材迁移防止装置市场：现况分析与预测（2023-2030）

Anti-retropulsion Devices Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计2023年至2030年，石材迁移防止装置市场的复合年增长率约为5.2%。预防结石迁移设备市场是指医疗设备产业的一部分，专注于设计在内视镜手术期间防止结石迁移的设备，特别是在泌尿外科领域。这些设备在输尿管镜检查等手术过程中使用，透过最大限度地降低结石返回肾臟或泌尿道其他部位的风险来提高结石清除的有效性和安全性。全球泌尿系结石的发生率和盛行率不断上升，增加了对有效和微创治疗方案的需求，这促进了泌尿内视镜手术中防结石迁移装置的采用。我是。例如，根据 NCBI 的数据，2019 年，全球发生了 11,55,52,140 例尿路结石病例，6,04,308.9 例估算 DALY，13,278.9 例死亡。此外，泌尿系结石预防设备技术的持续创新和进步，例如开发具有增强的可操作性、灵活性以及与内视镜设备相容性的设备，正在推动市场成长。

根据最终用户，市场分为医院、门诊手术中心等。在预测期内，医院预计将更多地采用石头迁移预防设备。医院因泌尿系统疾病（包括尿石症）而住院的人数急剧增加，并且需要在尿内视镜手术中使用防结石迁移装置以优化患者的治疗效果。此外，医院还配备了先进的基础设施、最先进的内视镜设备和专业设施，有助于在微创泌尿外科手术中有效使用防结石迁移装置。此外，医院通常拥有专门的泌尿外科部门和具有泌尿治疗专业知识的熟练医疗专业人员，促进了防结石迁移设备在泌尿外科治疗途径中的采用和整合。

为了更了解石材向后迁移防止装置产业的市场实施情况，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区） 、亚太地区（中国、日本、印度等亚太地区）以及世界其他地区。北美结石迁移预防装置市场的推动因素包括尿石症盛行率的不断上升、医疗保健专业人员和一般大众对结石迁移预防装置的认识不断提高、培训和教育市场的发展以及医疗成本的上升。是期待。例如，根据 census.gov 的数据，2020 年老年人口将增加 5,090 万人，从 1920 年的 490 万人（占美国总人口的 4.7%）增加到 5,580 万人（占美国总人口的 16.8%）。

目录

第一章 市场介绍

  • 市场定义
  • 主要目标
  • 利益相关者
  • 限制

第二章 研究方法或假设

  • 调查过程
  • 调查方法
  • 受访者简介

第三章市场总结

第 4 章执行摘要

第五章 COVID-19 对石材迁移防止装置市场的影响

第六章 2020-2030年全球石材后移防止装置市场收入

第 7 章 最终用户的市场洞察

  • 医院
  • 门诊手术中心
  • 其他

第八章按地区划分的市场洞察

  • 北美石材迁移防止装置市场
    • 美国
    • 加拿大
    • 其他北美
  • 欧洲石材迁移防止装置市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区石材迁移防止装置市场
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 其他地区石材迁移防止装置市场

第九章石材逆流防止装置市场动态

  • 市场驱动力
  • 市场挑战
  • 影响分析

第十章石材后移防止装置市场机会

第十一章石材后移防止装置市场趋势与见解

第十二章需求侧和供给面分析

  • 需求面分析
  • 供给侧分析

第十三章价值链分析

第14章价格分析

第15章 竞争场景

  • 竞争格局
    • 波特五力分析

第十六章公司简介

  • Accordion Medical
  • AstraZeneca pharma
  • Boston Scientific Corporation
  • Cook
  • Teleflex Incorporated
  • NIKSAN PHARMACEUTICAL
  • AdvaCare Pharma
  • Omicron Pharma
  • Cadila Pharmaceutical
  • ORFE MEDICAL

第十七章 免责声明

简介目录
Product Code: UMHE212560

The anti-retropulsion devices market is expected to register a CAGR of approx. 5.2% over the period of 2023-2030. The antiretropulsion device market refers to the segment of the medical device industry focused on devices designed to prevent stone migration during endoscopic procedures, particularly in the field of urology. These devices are utilized during procedures such as ureteroscopy to enhance the efficacy and safety of stone removal by minimizing the risk of stone migration back into the kidney or other parts of the urinary tract. The rising incidence and prevalence of urolithiasis (urinary tract stones) globally have heightened the demand for effective and minimally invasive treatment options, thereby driving the adoption of antiretropulsion devices in endourological procedures. For instance, according to the NCBI, In 2019, 11,55,52,140 incident cases of urolithiasis with 6,04,308.9 attributed DALYs and 13,278.9 deaths occurred globally. Furthermore, Continuous innovation and advancements in antiretropulsion device technology, including the development of devices with enhanced maneuverability, flexibility, and compatibility with endoscopic equipment, are driving market growth.

Based on the end-user, the market has been categorized into hospitals, ambulatory surgical centers, others. Among them, the hospital category is to witness higher adoption of anti-retropulsion devices during the forecast period. The hospitals are witnessing a surge in admissions for urological disorders, including urinary tract stones, necessitating the utilization of antiretropulsion devices in endourological procedures to optimize patient outcomes. Moreover, hospitals are equipped with advanced infrastructure, state-of-the-art endoscopic equipment, and specialized facilities that facilitate the effective utilization of antiretropulsion devices in minimally invasive urological procedures. Furthermore, hospitals often have specialized urology departments and skilled healthcare professionals proficient in endourological interventions, thereby fostering the adoption and integration of antiretropulsion devices in urological care pathways.

For a better understanding of the market adoption of the anti-retropulsion devices industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North America Anti-retropulsion Devices market is expected to continue to grow in the coming years, driven by the increasing prevalence of urolithiasis and growing awareness of anti-retropulsion devices among healthcare professionals and the general population, development of training and education and the rise in healthcare expenditure. For instance, in 2020, according to census.gov, The older population increased by 50.9 million, from 4.9 million (or 4.7% of the total U.S. population) in 1920 to 55.8 million (16.8%) in 2020.

Some of the major players operating in the market include Accordion Medical, AstraZeneca pharma, Boston cientific Corporation, Cook, Teleflex Incorporated, NIKSAN PHARMACEUTICAL, AdvaCare Pharma, Omicron Pharma, Cadila Pharmaceutical, ORFE MEDICAL.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Anti-retropulsion Devices Market
  • 2.2. Research Methodology of the Anti-retropulsion Devices Market
  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE ANTI-RETROPULSION DEVICES MARKET

6 GLOBAL ANTI-RETROPULSION DEVICES MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY END-USERS

  • 7.1. Hospitals
  • 7.2. Ambulatory surgical centers
  • 7.3. Others

8 MARKET INSIGHTS BY REGION

  • 8.1 NORTH AMERICA ANTI-RETROPULSION DEVICES MARKET
    • 8.1.1. U.S.
    • 8.1.2. Canada
    • 8.1.3. Rest of North America
  • 8.2 EUROPE ANTI-RETROPULSION DEVICES MARKET
    • 8.2.1. Germany
    • 8.2.2. U.K.
    • 8.2.3. France
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Rest of Europe
  • 8.3 ASIA PACIFIC ANTI-RETROPULSION DEVICES MARKET
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. Rest of Asia-Pacific
  • 8.4 REST OF THE WORLD ANTI-RETROPULSION DEVICES MARKET

9 ANTI-RETROPULSION DEVICES MARKET DYNAMICS

  • 9.1. Market Drivers
  • 9.2. Market Challenges
  • 9.3. Impact Analysis

10 ANTI-RETROPULSION DEVICES MARKET OPPORTUNITIES

11 ANTI-RETROPULSION DEVICES MARKET TRENDS & INSIGHTS

12 DEMAND AND SUPPLY SIDE ANALYSIS

  • 12.1. Demand Side Analysis
  • 12.2. Supply Side Analysis

13 VALUE CHAIN ANALYSIS

14 PRICING ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1 Porter's Five forces analysis

16 COMPANY PROFILED

  • 16.1. Accordion Medical
  • 16.2. AstraZeneca pharma
  • 16.3. Boston Scientific Corporation
  • 16.4. Cook
  • 16.5. Teleflex Incorporated
  • 16.6. NIKSAN PHARMACEUTICAL
  • 16.7. AdvaCare Pharma
  • 16.8. Omicron Pharma
  • 16.9. Cadila Pharmaceutical
  • 16.10. ORFE MEDICAL

17 DISCLAIMER